Several other research firms have also weighed in on SXS. HSBC lowered their price target on Spectris from GBX 2,750 ($35.93) to GBX 2,250 ($29.40) and set a hold rating on the stock in a research report on Tuesday, October 30th. Bank of America raised Spectris to a buy rating in a research report on Monday, October 15th. JPMorgan Chase & Co. reaffirmed an overweight rating on shares of Spectris in a research report on Thursday, February 7th. BNP Paribas lowered their price target on Spectris from GBX 2,550 ($33.32) to GBX 2,350 ($30.71) and set an outperform rating on the stock in a research report on Friday, January 25th. Finally, Morgan Stanley lowered their price target on Spectris from GBX 2,850 ($37.24) to GBX 2,800 ($36.59) and set an overweight rating on the stock in a research report on Wednesday, December 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of GBX 2,709.29 ($35.40).
LON:SXS opened at GBX 2,637 ($34.46) on Monday. Spectris has a twelve month low of GBX 2,225 ($29.07) and a twelve month high of GBX 2,869 ($37.49).
Spectris Company Profile
Spectris plc manufactures and sells measuring instruments and controls worldwide. It operates through four segments: Materials Analysis, Test and Measurement, In-line Instrumentation, and Industrial Controls. The Materials Analysis segment provides products and services, which enable customers to determine structure, composition, quantity, and quality of particles and materials during their research and development processes, when assessing materials before production, or during the manufacturing process.
Featured Article: What is the Rule of 72?
Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.